Growth Inhibition of Human Hepatoma and Bladder Carcinoma Cells by DNA Topoisomerae Inhibitor β-lapachone
![]() |
Choi Da Yean
(R&E Program, Busan Science Academy)
Lee Jae Il (R&E Program, Busan Science Academy) Chung Hyun Sup (R&E Program, Busan Science Academy) Seo Han Gyeol (R&E Program, Busan Science Academy) Woo Hyun Joo (Department of Biochemistry, Dongeui University College of Oriental Medicine Busan) Choi Yung Hyun (Department of Biochemistry, Dongeui University College of Oriental Medicine Busan) |
1 |
Schaffner-Sabba, K., K. H. Schmidt-Ruppin, W. Wehrli, A. R. Schuerch and J.W. Wasley. 1984. |
2 | Wang, C.H., Y.P. Tsao, H.J. Chen, H.L. Chen, H.W. Wang and S.L. Chen. 2000. Transcriptional repression of p21(Waf1/Cip1/Sdil) gene by c-jun through Sp1 site. Biochem. Biophys. Res. Commun. 270, 303-310 DOI ScienceOn |
3 | Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 DOI ScienceOn |
4 |
Weller, M., S. Winter, C. Schmidt, P. Esser, A. Fontana, J. Dichgans and P. Groscurth. 1997. Topoisomerase-I inhibitors for human malignant glioma: differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and |
5 | Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 DOI ScienceOn |
6 | Mathieu, N., J. Pirzio, M. A. Freulet-Marriere, C. Desmaze and J. Sabatier. 2004. Telomeres and chromosomal instability. Cell Mol. Life Sci. 61, 641-656 DOI ScienceOn |
7 |
Planchon, S. M., S. M. Wuerzberger-Davis, J. J. Pink, K. A. Robertson, W. G. Bommann and D. A. Boothman. 1999. Bcl-2 protects against |
8 |
Planchon, S. M., J. J. Pink, C. Tagliarino, W. G. Bornmann, M.E. Varnes and D. A. Boothman. 2001. |
9 | Rezler, E. M., D. J. Bearss and L. H. Hurley. 2002. Telomeres and telomerases as drug targets. Curr. Opin. Pharmacol. 2, 415-423 DOI ScienceOn |
10 | Rickers, A., N. Peters, V. Badock, R. Beyaert, P. Vandenabeele, B. Dorken and K. Bommert. 1999. Cleavage of transcription factor SPl by caspases during anti-lgM-induced B-cell apoptosis. Eur. J. Biochem. 261, 269-274 DOI ScienceOn |
11 | She, Q. B., A. M. Bode, W.Y. Ma, N.Y. Chen and Z. Dong. 2001. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610 |
12 | Sherr, C.J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60, 3689-3695 |
13 | Song, J., H. Ugai, H. Nakata-Tsutsui, S. Kishikawa, E. Suzuki, T. Murata and K.K. Yokoyama. 2003. Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements. Int. J. Mol. Med. 11, 547-553 |
14 |
Surh, Y.J., K.S. Chun, H.H. Cha, S.S. Han, Y.S. Keum, K.K. Park and S.S. Lee. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflanunatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- |
15 |
Goijman, S. G. and A. O. Stoppani. 1985. Effects of |
16 | Homayoun, V. and B. Sam. 1996. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: The telomere loss/DNA damage model of cell aging. Exp. Gerontol. 31, 295-301 DOI ScienceOn |
17 | Horikawa, J. and J. C. Barrett. 2003. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24, 1167-1176 DOI ScienceOn |
18 | Li, L., S. He, J. M. Sun and J. R. Davie. 2004. Gene regulation by Sp1 and Sp3. Biochem. Cell BioI. 82, 460-471 |
19 |
Hueber, A., P. Esser, K. Heimann, N. Kociok, S. Winter and M. Weller. 1998. The topoisomerase I inhibitors, camptothecin and |
20 |
Li, C. J., J. Averboukh and A B. Pardee. 1993. |
21 |
Liu, T. J., S. Y. Lin and Y. P. Chau. 2002. Inhibition of poly (ADP-ribose) polymerase activation attenuates |
22 | Lopes, J. N., F. S. Cruz, R. Docampo, M. S. Vasconcellos, M. C. Sampaio, A. V. Pinto and B. Gilbert. 1978. In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2- naphthoquinone derivatives against Trypanosoma cruzi. Ann. Trap. Med. Parasitol. 72, 523-531 |
23 | Maga, G. and U. Hubscher. 2003. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J. Cell Sci. 116, 3051-3060 DOI ScienceOn |
24 | Biggs, J. R., J. E. Kudlow and A. S. Kraft. 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/ CIP1 gene in U937 leukemic cells. J. BioI. Chem. 271, 901-906 DOI |
25 | Capranico, G., G. Zagotto and M. Palumbo. 2004. Development of DNA topoisomerase-related therapeutics: a short perspective of new challenges. Curr. Med. Chem. Anti-Cane. Agents 4, 335-345 DOI ScienceOn |
26 | Chiarugi, V., L. Magnelli and G. Basi. 1994. Apoptosis and the cell cycle. Cell. Mol. Biol. Res. 40, 603-612 |
27 |
Don, M. J., Y. H. Chang, K. K. Chen, L. K. Ho and Y. P. Chau. 2001. Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the |
28 | Choi, Y. H., W. H. Lee, K. Y. Park and L. Zhang. 2000. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91, 164-173 DOI |
29 |
Choi, Y. H., H. S. Kang and M. A. Yoo. 2003. Suppression of human prostate cancer cell growth by |
30 |
Choi, B. T., J. Cheong and Y. H. Choi. B-lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF- |
31 | EI-Deiry, W. S., T. Tokino, V. E. Velculesco, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, E. W. Mercer, K. W. Kinzler and B. Vogelstain. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 DOI ScienceOn |
32 | Bailly, C. 2000. Topoisomerase I poisons and suppressors as anticancer drugs. Curr. Med. Chem. 7, 39-58 DOI ScienceOn |
33 | Bakshi, R. P. and T. A. Shapiro. 2003. DNA topoisomerases as targets for antiprotozoal therapy. Mini Rev. Med. Chem. 3, 597-608 DOI ScienceOn |
34 | Bellamy, W. T. 1992. Prediction of response to drug therapy of cancer. A review of in vitro assays. Drugs 44, 690-708 DOI ScienceOn |
35 |
Kumi-Diaka, J. 2002. Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and |
36 |
Pardee, A. B., Y. Z. Li and C. J. Li. 2002. Cancer therapy with |
37 |
Guiraud, P., R. SteimanR, G. M. Campos-Takaki, F. SeigleMurandi and M. Simeon de Buochberg. 1994. Comparison of antibacterial and antifungal activities of lapachol and |
![]() |